Ceftriaxone
- Product NDC
- 71205-593
- 11-digit product format
- 712050593
- Labeler code
- 71205
- Product ID
- 71205-593_5f684b27-197e-45f0-b623-83a5fab20b0f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ceftriaxone
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Proficient Rx LP
- Application
- ANDA065329
- Marketing category
- ANDA
- Marketing start
- 2008-07-24
- Substance
- CEFTRIAXONE SODIUM
- Active strength
- 2 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ceftriaxone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFTRIAXONE SODIUM | 2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 023Z5BR09K |
| Rxcui | 1665046 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71205-593-01 | Ceftriaxone | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 2 |
| 71205-593-01 | Ceftriaxone | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71205-593 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [PROFICIENT RX LP] | 2 | Current NDC, Legacy NDC, 2 package rows | 20221112_fcf401df-bcdc-4773-a63b-9741c0f74b3d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71205-593-01 | 71205059301 | 1 VIAL in 1 CARTON (71205-593-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | 1 vial | 2021-07-23 | 0000-00-00 | No | No | Current |